What is Stifel Canada's Forecast for QIPT FY2025 Earnings?

Key Points

• Stifel Canada forecasts Quipt Home Medical's FY2025 earnings at ($0.13) per share, which is below the current consensus estimate of ($0.05) per share.
• The company recently reported a quarterly loss of ($0.07) per share, missing expectations by $0.10, with revenues of $58.30 million falling short of estimates of $80.37 million.
• Quipt Home Medical's stock price has experienced fluctuations, currently trading at $2.02, with a market cap of $87.92 million and a 12-month trading range between $1.35 and $3.27.

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Stifel Canada issued their FY2025 EPS estimates for shares of Quipt Home Medical in a report released on Tuesday, August 12th. Stifel Canada analyst J. Keywood forecasts that the company will post earnings per share of ($0.13) for the year. The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share. Stifel Canada also issued estimates for Quipt Home Medical's Q4 2025 earnings at $0.03 EPS.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last released its quarterly earnings data on Monday, August 11th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.10). The firm had revenue of $58.30 million for the quarter, compared to analysts' expectations of $80.37 million. Quipt Home Medical had a negative return on equity of 9.78% and a negative net margin of 4.30%.

QIPT has been the subject of a number of other reports. Benchmark reissued a "buy" rating and issued a $4.00 price target (down from $6.00) on shares of Quipt Home Medical in a research report on Wednesday, May 14th. Wall Street Zen lowered shares of Quipt Home Medical from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Finally, Canaccord Genuity Group restated a "hold" rating and issued a $1.70 price objective (down from $4.00) on shares of Quipt Home Medical in a research note on Tuesday, May 13th.

Quipt Home Medical Stock Up 1.7%

Shares of Quipt Home Medical stock traded up $0.03 during trading on Friday, hitting $2.02. 2,766 shares of the stock were exchanged, compared to its average volume of 533,516. Quipt Home Medical has a 12-month low of $1.35 and a 12-month high of $3.27. The stock has a market cap of $87.92 million, a price-to-earnings ratio of -8.42 and a beta of 0.59. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 0.85. The firm's 50-day moving average price is $2.01 and its 200 day moving average price is $2.20.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Kanen Wealth Management LLC increased its stake in shares of Quipt Home Medical by 108.4% during the first quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company's stock worth $6,919,000 after acquiring an additional 1,544,529 shares during the period. Wells Fargo & Company MN increased its stake in shares of Quipt Home Medical by 30.9% during the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company's stock worth $73,000 after acquiring an additional 5,625 shares during the period. BNP Paribas Financial Markets acquired a new position in shares of Quipt Home Medical during the fourth quarter worth about $137,000. Bank of America Corp DE increased its stake in shares of Quipt Home Medical by 13.5% during the fourth quarter. Bank of America Corp DE now owns 81,770 shares of the company's stock worth $249,000 after acquiring an additional 9,757 shares during the period. Finally, Northern Trust Corp increased its stake in shares of Quipt Home Medical by 2.8% during the fourth quarter. Northern Trust Corp now owns 257,402 shares of the company's stock worth $785,000 after acquiring an additional 7,095 shares during the period. 42.85% of the stock is currently owned by institutional investors and hedge funds.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.